Peter Boström - UTU Research Portal - UTU Research Portal

Go to Header Go to Navigation Go to Content Go to Footer

Peter Boström

- Professor,
Surgery (Department of Clinical Medicine)

peter.bostrom@utu.fi

: https://orcid.org/0000-0003-3647-0015

Go to first page

Go to previous page

13 of 24

Go to next page

Go to last page

Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type? (2020)
- European Urology
Kimmo Kettunen, Peter Boström, Pekka Taimen
Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results (2020)
- European Urology Open Science
Mikael Anttinen, Pietari Mäkelä, Antti Viitala, Pertti Nurminen, Visa Suomi, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström
Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation (2020)
- BMC Urology
Seikkula H, Boström PJ, Seppä K, Pitkäniemi J, Malila N, Kaipia A
Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial (2020)
- World Journal of Urology
Sell V., Ettala O., Montoya Perez I., Järvinen R., Pekkarinen T., Vaarala M., Seppänen M., Liukkonen T., Marttila T., Aaltomaa S., Kaasinen E., Boström P.J.
Uusia työkaluja paikallisesti edenneen ja etäpesäkkeisen eturauhassyövän lääkehoitoon (2020)
- Duodecim
Virtanen V, Rautiola H, Poutanen M, Boström PJ, Minn H, Sundvall M.
Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort (2020)
- Cancer Epidemiology
Seikkula H, Kaipia A, Hirvonen E, Rantanen M, Pitkäniemi J, Malila N, Boström PJ
Adverse Events During Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer (2019)
- Bladder Cancer
Salminen Antti P, Montoya Perez Ileana, Klén Riku, Ettala Otto O, Syvänen Kari T, Elo Laura L, Boström Peter J
ANO7 rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer (2019)
- Anticancer Research
Kaikkonen E, Ettala O, Nikulainen I, Taimen P, Lehtinen I, Bostrom PJ, Kellokumpu-Lehtinen PL, Schleutker J
Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer (2019)
- Carcinogenesis
Koivisto MK, Tervahartiala M, Kenessey I, Jalkanen S, Boström PJ, Salmi M
Clinical Utility of Mutant Antibody-Based Assays for Determination of Internally Cleaved and Intact Forms of Free Prostate-Specific Antigen (2019)
- The Journal of Applied Laboratory Medicine
Khan MFL, Soikkeli M, Routila E, Krannila S, Terävä J, Taimen P, Boström PJ, Pettersson K